Elixirgen Therapeutics, Inc

Elixirgen Therapeutics is a clinical-stage RNA therapeutics company focused on the discovery and development of innovative therapies, including cell and gene therapies. The Company is advancing three technologies to develop therapeutics for a broad spectrum of diseases including rare and genetic diseases, and aging-related disorders. Bobcat mRNATM technology uses a proprietary mRNA design to deliver large payloads such as full-length dystrophin, which is mutated in Duchenne muscular dystrophy. Preclinical data have demonstrated restoration of muscular function in DMD model mice with no safety findings associated with administration or treatment. Controllable self-replicating (c-srRNATM) technology controls the powerful gene expression of self-replicating...

Therapeutics,drug development,and biotechnology

Elixirgen therapeutics, inc operates in the Biotechnology industry.

Elixirgen therapeutics, inc's revenue is 11m - 100m

Elixirgen therapeutics, inc has 11 - 50 employees.